chrisvoncsefalvay/vaers-outcomes huggingface dataset:
fever of 101.2 chills & body aches sharp shooting / stabbing pain randomly all over body (in torso, extremity muscles and joints) tightness in chest major pain at injection site and by lungs/heart resting heartbeat of 108 bpm
The next morning after the shot I was feeling "off". This feeling continued on and off for over a year without anything happening. Turns out that feeling was "auras" which are technically seizures. I proceeded to have a seizure at work and one in my sleep(both in 2022). I had a seizure back in 2018 from a fake weed cartridge, but got off the medicine within 9 months, so I was off it some time around March/April of 2019. Felt completely normal after getting off of it, and life was pretty much normal again. I get the vaccine in September of 2021, and the very next day I start feeling super "off". I assumed it was the anxiety of the whole pandemic situation and brushed it off for a while. My family and extended family aren't believers in the covid vaccine, and all my friends are super pro-vaccine. So I didn't want to tell my family I was feeling off and have them immediately jump to conclusions, and I didn't want to tell my friends and have them think I'm some sort of crazy conspiracy theorist/antivaxxer. So I stayed silent as this feeling persisted, and brushed it off as anxiety(at least I hoped). Well yea, now it turns out I'm having frequent seizures that weren't happening before the vaccine, that started happing pretty much right after I took it.
palpitations; Soreness for 2.5 days; it is red and bruised/Redness; Swelling in the injection area; bruise at the injection site/bruising is about the size of a half dollar or a little bigger/bruising was purple; Warm to touch/feels hot to touch; She felt pain immediately from the injection; This is a spontaneous report from a contactable consumer. A 52-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9262), via an unspecified route of administration on 12Feb2021 at a single dose on right arm for COVID-19 vaccination. Medical history included history of reactions to vaccination (including swelling), cardiovascular disease and she had 3 stents placed in the last 3 years, ongoing coronary artery disease, small vessel disease, heart attack (when she was 50 years old. She has been having symptoms in the last could of years), blood pressure, angina, and high cholesterol. Concomitant medication included ticagrelor (BRILINTA) as blood thinner, ranolazine (RANOLAZINE EXTENDED RELEASE) for angina, rosuvastatin for high cholesterol, losartan for blood pressure, metoprolol to help her heart not work as hard, ezetimibe as cholesterol booster, and acetylsalicylic acid (ASPIRIN) as blood thinner. The patient experienced palpitations on an unspecified date which resulted in a recent hospitalization. The patient was reported to have taken the first dose of COVID-19 vaccine on 12Feb2021 and had soreness for 2.5 days since an unspecified date, then it resolved. She reported that she felt pain immediately from the injection on 12Feb2021 and some pain after the injection and she typically have reactions where she swells. On 20Feb2021, she developed a bruise at the injection site, and it was also warm to touch. The bruising was the size of a half dollar and it was hot to touch. She stated that the bruising was purple, and she never experienced that before. She wanted to know if this could be due to the vaccine. on 12Feb2021. On 21Feb2021, she had swelling in the injection area, it is red and bruised, and the bruising was about the size of a half dollar or a little bigger. The redness looked like it was a little less, but the bruising has been more prominent. She wanted to know if she should get the second dose on 05Mar2021, as scheduled, and if she does, will the reaction be worse? The patient underwent lab tests and procedures which included exploratory tests: which revealed small vessel disease on an unknown date. The outcome of the event "Soreness for 2.5 days" was recovered; "She felt pain immediately from the injection", "it is red and bruised/Redness" was recovering; and "bruise at the injection site/bruising is about the size of a half dollar or a little bigger/bruising was purple", "Warm to touch/feels hot to touch" and "Swelling in the injection area" was not recovered, and for palpitations was unknown.
After midnight, I felt chills, headache and feverish. Then I had Fast heart rate. On Sept. 6, 2019 I called my doctor's office + reported on my situation. Nurse advised me to take Tylenol for headache that morning. No more chills, fever and fast heart rate in the morning of SepT. 6.
Narrative: Patient has afib, and LLL multiple subsegmental PE that occurred in Nov 2021. The PE occurred about a week after cardioversion and admission to a hospital and about 10 days after a moderna covid booster.
her cousin's son experienced severe headaches with episodes of vomiting; her cousin's son experienced severe headaches with episodes of vomiting; This spontaneous report was received from a consumer referring to her cousin's son of age 18 to 20. The patient's concomitant medication, pertinent medical history and drug reactions/allergies were unknown.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (strength, dose, route, lot # and expiration were unknown) for prophylaxis. Other suspect therapies included diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid (TDAP), and pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) (reported as pneumonia vaccine but unsure which one) (strength, dose, route, indication, lot # and expiration were unknown). The patient received the 3 vaccines during an office visit.  On unknown dates, the patient experienced severe headaches with episodes of vomiting. The patient had sought medical attention. It was unknown whether any lab diagnostics or studies were performed or not. It was unknown if the patient received treatment. The outcome of headache and vomiting was reported as recovered. The causality assessment between the events and all suspect vaccines was not reported.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information has been received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In 2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), at a medical center/health care facility (by an unspecified healthcare professional) as recommended for routine adult health maintenance for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. Later in 2015, the patient was treated (by an unspecified health care professional) at another medical center/hospital for a blistering vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events is unknown. Additional information has been requested.
BP at time of visit - 136/85 HR - 79BPM 20 minutes post vaccination 117/69. Pt sent to drink water and sit in waiting room. 10 min. later BP 139/81. All BP's done sitting in (L) arm. Pt denied any complaints. Dr and RN remained with pt.
Patient reports that 25 minutes prior to arrival she received the 1st maderna vaccine and now complains of a rash with associated itchiness that is worsening. Patient also reports a history of similar reactions to vaccines in the past. Denies wheezing or difficulty breathing. patient received prednisone and Benadryl in the ER.
Flu like symptoms; Low fever; Body aches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 30Apr2022 at 12:00 as dose 4 (booster), single (Lot number: fk9893) at the age of 57 years intramuscular, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing), notes: Other medical history: Hypothyroidism; "Known allergies: PCN" (unspecified if ongoing), notes: Known allergies: PCN. Concomitant medication(s) included: SYNTHROID; ESTRADIOL; PROGESTERONE; SUDAFED [GUAIFENESIN;PSEUDOEPHEDRINE HYDROCHLORIDE]. Vaccination history included: BNT162b2 (Dose Number: 3, Batch/Lot No: fj1620, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 19Nov2021, when the patient was 57-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 2, Batch/Lot No: el3247, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 15Mar2021, when the patient was 56-year-old, for COVID-19 immunization; BNT162b2 (Dose Number: 1, Batch/Lot No: el3247, Location of injection: Arm Left, Route of Administration: Intramuscular), administration date: 22Feb2021, when the patient was 56-year-old, for COVID-19 immunization. The following information was reported: PAIN (non-serious) with onset 01May2022, outcome "not recovered", described as "Body aches"; INFLUENZA LIKE ILLNESS (non-serious) with onset 01May2022, outcome "not recovered", described as "Flu like symptoms"; PYREXIA (non-serious) with onset 01May2022, outcome "not recovered", described as "Low fever". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of influenza like illness, pyrexia, pain.  No follow-up attempts are needed. No further information is expected.
patient received first dose on 30Dec2020 and has not received second dose yet; A spontaneous report was received from a consumer concerning male patient of unknown age, who received Moderna's COVID-19 vaccine first dose and has not received second dose yet.   The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 (Lot number:025L20A) unknown route of administration on 30 Dec 2020 for prophylaxis of COVID-19 infection.    Patient stated he had missed his email for being able to return for his second dose. His first dose was on 30-Dec-2020. He returned to the same clinic on 28-Jan-2021 but they turned him away and told he will receive an email and he is still waiting on that. During a follow up call patient stated he was able to get in touch with an alternative vaccination site who advised him to come on 12-Feb-2021 and see if they will vaccinate him. Patient was unsure if they will vaccinate him since last time he showed up without an appointment and he was turned away.  No treatment information was provided.   Action taken with the second dose of mRNA-1273 in response to the event was not reported.   The event, Patient received first dose on 30-Dec-2020 and has not received second dose yet was considered resolved.; Reporter's Comments: This case concerns a male of unknown age who experienced a nonserious unexpected event of Inappropriate schedule of product administration for mRNA-1273 (lot # 025L20A) without associated adverse events.  Patient received first dose mRNA-2173 on 30-Dec-2020 and has not yet received the second dose.  The missed second dose of mRNA-1273 occurred 1 month and 13 days after the first dose of mRNA-1273. Further information has been requested.
At site of administration there was local warmth, erythema without fluctuance (like cellulitis) approx 15 cm diameter with vesicular patches on cellulitis. Also has maculopapular rash over legs, trunk, arms, with some lesions having vesicular formation with clear drainage.
Sore throat; Fatigue; Headache; Chills; Nausea; Lymph nodes swollen; Injection site pain, swelling, redness; Injection site pain, swelling, redness; Injection site pain, swelling, redness; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 01-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), LYMPHADENOPATHY (Lymph nodes swollen), VACCINATION SITE PAIN (Injection site pain, swelling, redness), VACCINATION SITE SWELLING (Injection site pain, swelling, redness) and VACCINATION SITE ERYTHEMA (Injection site pain, swelling, redness). At the time of the report, OROPHARYNGEAL PAIN (Sore throat), FATIGUE (Fatigue), HEADACHE (Headache), CHILLS (Chills), NAUSEA (Nausea), LYMPHADENOPATHY (Lymph nodes swollen), VACCINATION SITE PAIN (Injection site pain, swelling, redness), VACCINATION SITE SWELLING (Injection site pain, swelling, redness) and VACCINATION SITE ERYTHEMA (Injection site pain, swelling, redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided.
Headache, Myalgia, Fever, NauseaVomiting, chills, decreased appetite, injection site pain and redness Saw PCP and had blood work done for increased nausea and fatigue on 1/7/2021.
I woke up in the middle of the first night after receiving 2nd dose of Moderna.  I had a fever, chills and muscle aches, and extreme fatigue.  Those symptoms lasted approx 3 days.  Two days after the vaccination I also became extremely nauseous.  I was anticipating all of these symptoms.  On the 3rd and 4th days after the vaccine most of the symptoms disappeared but I received some new ones that I was not expecting.  I suddenly felt a large amount of despair and hopelessness.  I had suicidal thoughts.  I had panic attacks and anxiety.  I had paranoia.  I did not feel like I had long to live, or anything to live for.  By 20 Apr all of these emotional and mental side effects were completely gone.
pt inadvertently recv 1ml of flu vax instead of .5ml;2 days p/vax pt devel a fever of 102, sore throat & flu sx;addtl info recv 13NOV96,indicated that the pt recovered;@ that time the reporter stated that the pt husband devel similar sx;
pt recv vax on 08jan97; 19jan97 pt devel a rash w/ about 10 lesions.PCR analysis of specimen from the pt's rash revealed wild-type varicella virus;
Severe allergic reaction; Allergy to Polysorbate 80 which is a component of Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Severe allergic reaction) and ALLERGY TO VACCINE (Allergy to Polysorbate 80 which is a component of Moderna vaccine) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Severe allergic reaction) and ALLERGY TO VACCINE (Allergy to Polysorbate 80 which is a component of Moderna vaccine). At the time of the report, HYPERSENSITIVITY (Severe allergic reaction) and ALLERGY TO VACCINE (Allergy to Polysorbate 80 which is a component of Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details not reported.
Almost immediately after getting the second vaccine I felt as if I had been given a strong dose of an EPI pen, my heart started to race, I could literally feel the pulse throughout my body, my face went completely red and flushed but I was breathing ok so it was not like previous anaphylaxis I had encountered. This lasted for about 2 to 3 minuets and then I felt fine so I returned to work. Two days following I started to run a fever, felt extremely fatigued and aching, dizziness and headaches I stayed in bed for two days. Since that time I have had ongoing issues with my heart racing and feeling SOB and also episodes of my blood pressure elevating, the racing heart seems to be worse at night when I lay down. I made an appt with my PCM in April because the episodes were continuing which concerned me, she did not seem concerned and thought it was not vaccine related, I disagree, I know my own body better than anyone and something is not right.
Left side the mom noticed a sore developed and then it became a circular burn about the size of a quarter.
IM Flu shot was given in the shoulder and not in the Deltoid.  After an 1 1/2 after shot was given client states it was sore and and could barely raise her arm.  Fingers started tingling and throbbing.  Pain rated a 7 with movement.  Client reported problem to the manager.
neuropathy in feet and in lower limbs; This spontaneous report was received from a physician assistant, referring to a 12-year-old female patient. Information regarding the patient's pertinent medical history, concurrent condition, drug reactions/allergies and concomitant medication was not provided.   On an unknown date in August 2020, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (dose, strength, route, lot# and expiration date were not provided) for prophylaxis.    On an unknown date in August 2021 (also reported as about a month ago), the patient experienced pain and neuropathy in feet and in lower limbs and the patient was hospitalized for 2x weeks. The patient had experienced significant disability for 2x weeks.The outcome of the event was unknown. The reporter did not think this event was Guillain-Barre syndrome.  The reporter considered the event of pain and neuropathy in feet and in lower limbs to be not related to HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast)(GARDASIL 9).     Upon internal review, the event of pain and neuropathy in feet and in lower limbs was determined as hospitalization, medically significant and disability. Company Causality Assessment: Based on the limited information currently available for this case, a reasonable possibility to suggest a relationship between the GARDASIL 9 vaccine and the reported event of neuropathy peripheral cannot be established. Additional information regarding patient's medical history, concurrent conditions, concomitant medications, vaccination/event onset date, additional clinical details, diagnostic evaluation and follow up is needed for a proper assessment.  Company Comment- No changes to the product safety information are warranted at this time. Continues to monitor the safety profile of the product.
Right leg and thigh erythema 18 x 14cm flat, minimal tenderness. Started 08/16/2005 after immunization 08/15/2005.
Per dad, pt had a seizure right after administration. Pt was sitting, sweating and could not breathe, felt nauseas also. I had pt seat and breathe in and out on a paper bag. He was fine after a few minutes. Called pt to check up on him. Pt is doing fine at home and is okay.
Patient reports soreness in arm that has persisted since getting the vaccine. She felt no pain during vaccine administration, only after.
Patients received the vaccination after a temperature excursion; Patients received the vaccination after a temperature; No Adverse Event; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patients received the vaccination after a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the vaccination after a temperature) and NO ADVERSE EVENT (No Adverse Event) in an elderly female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 049D22A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patients received the vaccination after a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the vaccination after a temperature) and NO ADVERSE EVENT (No Adverse Event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patients received the vaccination after a temperature excursion), PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the vaccination after a temperature) and NO ADVERSE EVENT (No Adverse Event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No Adverse Event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (Patients received the vaccination after a temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patients received the vaccination after a temperature).    No concomitant medications were reported.   The facility had a temperature excursion in the freezer. They had an inspection and saw that their DDL was not recording the temperatures.  At the time of the excursion, the vaccine was in frozen storage. The vaccines were in broken cartons with vial size of 2.5 mL and 5.5 mL.  Because only manual recording was done twice a day, the maximum and minimum temperatures reached by the vials were unknown.  The excursion duration was unknown. The vaccine was returned to the freezer.   The visual inspection showed the vaccine state as still frozen.  The vial underwent temperature excursion for the first time.  No treatment information was provided by the reporter.
This spontaneous report was received from a pharmacist and refers to a 61 year old female patient. The patient had no drug reactions or allergies. The patient had no pertinent medical history. On 06-JUL-2015, the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml, once, subcutaneous (lot # and expiration date were not provided), to prevent shingles. The patient took no concomitant medications. On 22-AUG-2015, the patient developed "a rash on her chest and back" which was "very hot and burning". The patient sought medical attention by seeing her unspecified healthcare provider on an unspecified date in 2015. The patient received prednisone (manufacturer unknown), hydroxyzine (manufacturer unknown) and BENADRYL as the treatment for the event but "they weren't really working". No lab diagnostics studies were performed. At the time of reporting, the patient did not recover from the event. The relatedness between the event and ZOSTAVAX was not reported. This is one of several reports concerning the same patient. Additional information has been requested.